Endoluminal Suturing Devices Market Size & Growth Forecast 2027–2036, By Segments (Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Endoluminal Suturing Devices Market size stood at USD 89.58 million in 2026 and is predicted to grow at a 9.6% CAGR from 2027 to 2036, exceeding USD 224.04 million by 2036. The industry revenue for 2027 is calculated at USD 96.82 million.
Get more details on this report
Request Free Sample ReportEndoluminal Suturing Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 46.00% market share in 2026, supported by widespread minimally invasive gastrointestinal procedures, advanced endoscopy infrastructure, and routine integration of suturing devices into therapeutic workflows.
- Asia Pacific is projected to grow at an 11.42% CAGR, driven by expanding endoscopy capabilities, rising adoption of minimally invasive procedures, and improving access to advanced therapeutic interventions.
Segment Momentum
- Gastrointestinal Surgery held a 37.31% share in 2026, supported by broad use across minimally invasive procedures requiring reliable tissue approximation and closure during complex endoscopic interventions.
- Ambulatory Surgical Centers are the fastest-growing end users as more minimally invasive procedures shift to outpatient settings that emphasize efficiency, faster turnover, and shorter patient stays.
Market Expansion Drivers
- Rising adoption of minimally invasive gastrointestinal and bariatric surgical procedures.
- Integration of robotic-assisted and precision endoscopic suturing technologies.
- Increasing prevalence of obesity and GI disorders driving surgical intervention volumes.
Leading Market Participants
- Leading players in the endoluminal suturing devices market include Apollo Endosurgery, Inc. (USA), Johnson & Johnson (USA), Medtronic plc (Ireland), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (USA), Sutrue Ltd. (United Kingdom), Cook Medical (USA), Ovesco Endoscopy AG (Germany), USGI Medical (USA), Boston Scientific Corporation (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 89.58 million
- 2027 Estimated Market Size: USD 96.82 million.
- Projected Market Size: USD 224.04 million by 2036
- Growth Forecast: 9.6% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Gastrointestinal Surgery (Application) | Hospitals (End-use)
- Emerging Opportunity Segment: Gastresophageal Reflux Surgery (Application) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising adoption of minimally invasive gastrointestinal and bariatric surgical procedures
The endoluminal suturing devices market will benefit from the growing preference for minimally invasive gastrointestinal and bariatric procedures, as clinicians increasingly seek techniques that reduce surgical trauma, recovery time, and procedure-related complications. Endoluminal suturing enables tissue approximation and closure through flexible endoscopic access, supporting applications such as bariatric revision procedures, defect closure, and gastrointestinal tissue repair without requiring conventional open or highly invasive surgery. Broader adoption of therapeutic endoscopy, combined with improvements in endoscopic visualization and suturing capabilities, is expanding the range of procedures that can be performed through minimally invasive approaches.
Integration of robotic-assisted and precision endoscopic suturing technologies
Integration of robotic assistance and precision-control capabilities is creating new opportunities for the endoluminal suturing devices market by improving the accuracy, stability, and repeatability of complex tissue-approximation procedures. Advanced systems can provide enhanced instrument control and support more precise suture placement in anatomically challenging gastrointestinal locations, helping clinicians manage procedures that require consistent tension and controlled tissue handling. The development of sophisticated endoscopic platforms, improved articulation, and technology-enabled procedural guidance is also supporting greater confidence in advanced suturing techniques among specialized healthcare providers.
Increasing prevalence of obesity and GI disorders driving surgical intervention volumes
The increasing burden of obesity and gastrointestinal disorders is contributing to higher demand for therapeutic interventions, supporting greater utilization of endoluminal suturing technologies. Rising numbers of patients requiring bariatric treatment, revision procedures, gastrointestinal defect closure, and management of complications create a broader clinical need for minimally invasive tissue-repair solutions. As healthcare providers increasingly incorporate endoscopic approaches into treatment pathways, the ability of suturing devices to support closure, reinforcement, and tissue remodeling procedures is strengthening their role across a wider range of gastrointestinal interventions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising adoption of minimally invasive gastrointestinal and bariatric surgical procedures | 2.40% | High | North America, Asia Pacific | High | Near Term |
| Integration of robotic-assisted and precision endoscopic suturing technologies | 2.10% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Increasing prevalence of obesity and GI disorders driving surgical intervention volumes | 1.90% | High | North America, Europe | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the endoluminal suturing devices market, North America held the largest share of 46.00% in 2026, supported by advanced healthcare infrastructure, widespread adoption of minimally invasive procedures, and strong clinical acceptance of endoscopic treatment approaches. The region benefits from sophisticated hospital systems, experienced gastroenterology and surgical specialists, and continued emphasis on procedures that can reduce recovery time and improve patient outcomes. Favorable reimbursement environments and ongoing investment in advanced medical technologies further reinforce demand, while the increasing use of endoscopic interventions creates a strong foundation for adoption of suturing solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing region, driven by expanding healthcare infrastructure, rising access to specialized gastrointestinal care, and growing awareness of minimally invasive treatment options. Improvements in hospital capabilities across emerging healthcare markets are increasing the availability of advanced endoscopic procedures, while expanding healthcare expenditure and a growing patient population are supporting demand for modern intervention technologies. Increasing physician familiarity with minimally invasive techniques and investments in technologically equipped medical facilities are also expected to strengthen regional adoption.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Endoscopy FocusGermany emphasizes high-precision endoscopic procedures supported by advanced endoluminal suturing devices in specialized healthcare centers. Clinical adoption is encouraged by demand for durable tissue closure solutions that integrate with modern therapeutic endoscopy practices.
France 🇫🇷
Specialized GI InterventionFrance supports the use of endoluminal suturing devices in specialized gastrointestinal centers seeking minimally invasive treatment alternatives. Clinical interest centers on reliable tissue approximation technologies that improve therapeutic endoscopy and postoperative patient management.
Italy 🇮🇹
Endoscopy Practice ExpansionItaly is gradually expanding the adoption of endoluminal suturing devices as healthcare providers broaden advanced endoscopic capabilities. Hospitals increasingly evaluate solutions that simplify complex gastrointestinal procedures while supporting efficient tissue closure and patient care.
Japan 🇯🇵
Advanced Therapeutic EndoscopyJapan continues to strengthen adoption of endoluminal suturing devices through sophisticated endoscopy programs focused on minimally invasive gastrointestinal interventions. Healthcare facilities value technologies that enhance procedural accuracy while supporting efficient patient recovery.
South Korea 🇰🇷
Procedure Efficiency EnhancementSouth Korea increasingly incorporates endoluminal suturing devices into advanced endoscopic procedures to improve clinical outcomes and procedural flexibility. Hospitals prioritize technologies that complement expanding minimally invasive treatment capabilities and physician expertise.
United States 🇺🇸
Minimally Invasive ProceduresThe U.S. continues to expand the use of endoluminal suturing devices across advanced gastrointestinal and bariatric procedures. Healthcare providers increasingly adopt technologies that improve procedural efficiency, reduce surgical intervention, and support minimally invasive treatment pathways.
Segment Leadership and Growth Trends
Endoluminal Suturing Devices Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Gastrointestinal Surgery (Largest Segment) vs Gastresophageal Reflux Surgery (Fastest-Growing Segment)
Gastrointestinal surgery held the largest share of 37.31% in 2026 in the endoluminal suturing devices market, driven by the expanding use of minimally invasive techniques for procedures involving the digestive tract. Endoluminal suturing devices enable clinicians to perform tissue approximation and closure through less invasive approaches, helping support procedural efficiency while reducing the need for extensive surgical access. Growing preference for minimally invasive gastrointestinal interventions, together with continued advances in endoscopic techniques, is strengthening demand for specialized suturing technologies in this application.
Gastresophageal reflux surgery is emerging as the fastest-growing application as clinicians increasingly explore minimally invasive approaches for managing persistent reflux conditions. Endoluminal suturing can support tissue modification and procedural interventions without the extensive access associated with conventional surgery, aligning with broader demand for less invasive treatment options. Greater attention to durable reflux management, improved endoscopic capabilities, and patient preference for procedures associated with reduced surgical burden are contributing to expanding adoption in this application.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals represented the largest end-use segment of the endoluminal suturing devices market in 2026, reflecting their central role in performing complex gastrointestinal and minimally invasive procedures. Hospitals typically provide comprehensive surgical infrastructure, specialist expertise, advanced endoscopic capabilities, and postoperative support, making them important settings for the use of sophisticated suturing devices. The concentration of specialized procedures and multidisciplinary care within hospital environments continues to sustain demand for endoluminal technologies.
Ambulatory surgical centers are witnessing faster growth as healthcare delivery increasingly shifts appropriate minimally invasive procedures toward outpatient settings. These facilities can provide specialized interventions with streamlined workflows, shorter stays, and lower dependence on extensive inpatient infrastructure. As endoscopic and suturing techniques become more suitable for controlled outpatient procedures, the ability of ambulatory centers to deliver efficient procedural care is encouraging greater adoption of endoluminal suturing devices in this setting.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Surgery, Others | Gastrointestinal Surgery | Gastresophageal Reflux Surgery |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Key companies in the endoluminal suturing devices market:
1. Apollo Endosurgery Inc. (USA)
2. Johnson & Johnson (USA)
3. Medtronic plc (Ireland)
4. Endo Tools Therapeutics S.A. (Belgium)
5. ErgoSuture (USA)
6. Sutrue Ltd. (United Kingdom)
7. Cook Medical (USA)
8. Ovesco Endoscopy AG (Germany)
9. USGI Medical (USA)
10. Boston Scientific Corporation (USA)
The endoluminal suturing devices market is witnessing technological advancement through the development of minimally invasive surgical tools with enhanced precision and maneuverability. Companies are emphasizing improved tissue closure efficiency, ergonomic device designs, and compatibility with robotic-assisted procedures to strengthen clinical outcomes. Rising preference for less invasive gastrointestinal treatments is further supporting market expansion.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery Inc. (USA) | |||||||
| Johnson & Johnson (USA) | |||||||
| Medtronic plc (Ireland) | |||||||
| Endo Tools Therapeutics S.A. (Belgium) | |||||||
| ErgoSuture (USA) | |||||||
| Sutrue Ltd. (United Kingdom) | |||||||
| Cook Medical (USA) | |||||||
| Ovesco Endoscopy AG (Germany) | |||||||
| USGI Medical (USA) | |||||||
| Boston Scientific Corporation (USA). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| USGI MEDICAL | Feb-24 | USGI MEDICAL established a strategic distribution partnership with RMS Medical Devices to increase the availability of its Incisionless Operating Platform (IOP) and POSE2.0 technology in the Benelux region. This move facilitates broader clinical access to endoluminal suturing for bariatric interventions, strengthening the company's European commercial footprint and operational reach. |
| Ethicon | Nov-23 | Ethicon (Johnson & Johnson MedTech) launched the ETHIZIA Hemostatic Sealing Patch, featuring unique dual-sided active synthetic polymer technology. The patch received CE Mark approval for internal organ hemostasis, representing a significant technological advancement in surgical bleeding control and defect closure, further diversifying Ethicon’s suite of supportive procedural solutions. |
| Boston Scientific | Apr-23 | Boston Scientific completed the acquisition of Apollo Endosurgery, integrating the OverStitch endoscopic suturing system into its endoscopy division. This acquisition significantly enhanced Boston Scientific’s capabilities in minimally invasive bariatric and gastrointestinal defect closure, allowing the company to offer a comprehensive, integrated suite of therapeutic solutions for endoluminal interventions. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Endoluminal Suturing Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Reusability | Single-Use Devices, Reusable Devices |
| Purchasing Model | Direct Purchase, Group Purchasing Organization (GPO) Contracts, Distributor-Mediated Purchase, Capital Equipment Leasing |
| Specialty Department | Gastroenterology, Bariatric Surgery, General Surgery, Interventional Endoscopy |
Endoluminal Suturing Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Procedure Adoption and Clinical Utilization Assessment |
|
| Physician Training and Center of Excellence Landscape |
|
| Unmet Clinical Needs and Innovation White Space |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the endoluminal suturing devices market?
How is the endoluminal suturing devices industry size expected to evolve during the forecast period?
How is the expansion of minimally invasive gastrointestinal and bariatric procedures driving adoption in the endoluminal suturing devices market?
What impact is robotic-assisted suturing technology having on clinical adoption in the endoluminal suturing devices market?
Why is gastrointestinal surgery the leading application in the endoluminal suturing devices market?
Which end-use segment is growing the fastest in the endoluminal suturing devices market?
Why is North America the leading market for endoluminal suturing devices?
What is fueling endoluminal suturing devices market growth in Asia Pacific?
Which companies are driving growth in the endoluminal suturing devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization